Effect of somatostatin in the Syrian hamster bearing a transplantable islet-cell tumor.

The influence of somatostatin (SRIF) on blood glucose, plasma insulin and plasma glucagon was studied in hamsters bearing a transplantable islet-cell tumor secreting insulin and glucagon as well as in normal controls. Fed anesthetized animals were infused intraperitoneally either at a dose of 10 microgram in 15 min or of 150 microgram in 30 min, and intravenously at a dose of 250 microgram in 30 min. Blood was withdrawn from the jugular vein before and after infusion. Before the infusions, tumor bearing animals (TB) had lower blood glucose, markedly elevated plasma glucagon and slightly lower plasma insulin by comparison with normal hamsters (N). Both doses of somatostatin infused by the intraperitoneal route produced a slight but significant hypoglycemia in TB hamsters but not in normals. Ten microgram SRIF did not affect insulin and plasma glucagon levels whereas 150 microgram SRIF significantly depressed plasma insulin in both types of hamsters (N and TB). This latter dose of SRIF decreased plasma glucagon in normal but not in tumor-bearing hamsters. Intravenous infusion of 250 microgram SRIF did not reduce the hyperglucagonemia of TB hamsters either. These results indicate that somatostatin does not reduce the hyperglucagonemia due to the transplantable islet-cell tumor but nevertheless decreases blood glucose and plasma insulin.
AuthorsA S Luyckx, P J Lefebvre
JournalHormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et meĢtabolisme (Horm Metab Res) Vol. 10 Issue 2 Pg. 105-10 (Mar 1978) ISSN: 0018-5043 [Print] GERMANY, WEST
PMID206496 (Publication Type: Journal Article)
Chemical References
  • Blood Glucose
  • Insulin
  • Somatostatin
  • Glucagon
  • Adenoma, Islet Cell (blood, secretion)
  • Animals
  • Blood Glucose (metabolism)
  • Cricetinae
  • Glucagon (blood)
  • Insulin (blood)
  • Mesocricetus
  • Neoplasm Transplantation
  • Neoplasms, Experimental (blood, secretion)
  • Pancreatic Neoplasms (blood, secretion)
  • Somatostatin (administration & dosage, pharmacology)
  • Transplantation, Homologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: